Summary
The stock has recorded a trading volume of 188 shares,. Its Average Traded Price (ATP) is ₹49.72, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 18 @ ₹49.68.
Eiko Lifesciences has an upper circuit limit of ₹59.07 and a lower circuit limit of ₹39.39. The total value traded stands at ₹9347.36, and the delivery percentage for the day is 97.77%.
The stock is currently traded with a market lot size of 1. Eiko Lifesciences also offers a dividend yield of 0%.
Eiko Lifesciences Share Price Chart
Eiko Lifesciences Share Key Metrics
Volume
188.00
Market Cap
73.53 CR
LTQ@LTP
18@49.68
ATP
49.72
Var Margin
25 %
Circuit Range
39.39-59.07
Delivery %
97.77 %
Value
9347.36
ASM/GSM
No
Market Lot
1
Eiko Lifesciences Resistance and Support
Pivot 49.75
Resistance
First Resistance
50.27
Second Resistance
51.32
Third Resistance
51.84
Support
First Support
48.7
Second Support
48.18
Third Support
47.13
Eiko Lifesciences Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2024-25
- 2025-26
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Eiko Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-12 | Quarterly Results |
| 2026-05-26 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-12-11 | Others |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-14 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-25 | Rights issue of Equity Shares |
| 2024-10-19 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Eiko Lifesciences News
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Restructuring
Eiko LifeSciences' wholly-owned subsidiary, Eiko Scientific Solutions LLP, has formed a 50:50 joint venture named Oval Eiko Resources Private Limited. The new entity marks the company's entry into renewable energy, specifically compressed biogas production and distribution.
Nov 13 2026 16:05:10
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Restructuring
Eiko Lifesciences' wholly-owned subsidiary, Eiko Scientific Solutions LLP, is forming a 50:50 joint venture with Oval Projects Engineering. The new entity, Oval Eiko Resources Pvt Ltd, will focus on compressed bio gas production and distribution.
Nov 05 2026 21:31:01
Eiko Lifesciences Ltd - 540204 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. On Thursday, 05Th November, 2026.
EIKO Lifesciences reported Q2 FY27 cons. revenue of ₹17.72 crores (up 51.8% YoY) and net profit of ₹1.56 crores (up 21.7% YoY). Additionally, its wholly-owned subsidiary, Eiko Scientific Solutions LLP, will form a 50-50 joint venture named Oval Eiko Resources Pvt Ltd with Oval Projects Engineering Ltd to enter compressed bio gas production.
Nov 05 2026 16:57:44
Eiko Lifesciences Management
| Name | Position |
|---|---|
| Chintan Doshi | Company Secretary & Compliance Officer |
| Laxmikant Ramprasad Kabra | Chairman |
Eiko Lifesciences Similar Stocks
Sunil Healthcare Ltd.
70.00
-2.05 (2.85%)
APT Packaging Ltd.
65.69
3.12 (4.99%)
Shakti Polytarp Ltd.
45.00
0.00 (0.00%)
TPI India Ltd.
12.68
0.28 (2.26%)
Kisaan Parivar Industries Ltd.
9.44
0.27 (2.94%)
Tokyo Plast International Ltd.
77.20
0.00 (0.00%)
Polychem Ltd.
1828.00
13.50 (0.74%)
Hardcastle & Waud Manufacturing Company Ltd.
834.95
19.95 (2.45%)
Eiko Lifesciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in EIKO
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC